These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 151869)

  • 21. Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea.
    Aquilonius SM; Eckernås SA; Sundwall A
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):669-77. PubMed ID: 125784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.
    Buck SH; Burks TF; Brown MR; Yamamura HI
    Brain Res; 1981 Mar; 209(2):464-9. PubMed ID: 6164436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Huntington's chorea and neurofibromatosis (von Recklinghausen's disease). Concurrence of two generations of a family with inherited Huntington's chorea].
    Dörstelmann D; Kerschensteiner M; Markus E; Sturm KW
    Z Neurol; 1971 Apr; 199(1):39-45. PubMed ID: 4102748
    [No Abstract]   [Full Text] [Related]  

  • 24. Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.
    Glass M; Faull RL; Dragunow M
    Neuroscience; 1993 Oct; 56(3):523-7. PubMed ID: 8255419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography.
    Postert T; Lack B; Kuhn W; Jergas M; Andrich J; Braun B; Przuntek H; Sprengelmeyer R; Agelink M; Büttner T
    J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):457-62. PubMed ID: 10486391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chorea.
    Klawans HL
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):536-40. PubMed ID: 2445458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain amino compounds in a Huntington's disease patient on isoniazid therapy.
    Perry TL; Wall RA; Hansen S
    Neurology; 1985 May; 35(5):755-8. PubMed ID: 3157886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcortical afferent projection systems in Huntington's chorea.
    Mann DM
    Acta Neuropathol; 1989; 78(5):551-4. PubMed ID: 2530750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue.
    Spokes EG
    Brain; 1980 Mar; 103(1):179-210. PubMed ID: 6102490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Neuropathology of Huntington's Disease.
    Waldvogel HJ; Kim EH; Tippett LJ; Vonsattel JP; Faull RL
    Curr Top Behav Neurosci; 2015; 22():33-80. PubMed ID: 25300927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea.
    Bird ED; Mackay AV; Rayner CN; Iversen LL
    Lancet; 1973 May; 1(7812):1090-2. PubMed ID: 4122011
    [No Abstract]   [Full Text] [Related]  

  • 32. Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects.
    Spokes EG; Garrett NJ; Rossor MN; Iversen LL
    J Neurol Sci; 1980 Dec; 48(3):303-13. PubMed ID: 6449563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABA receptor binding and endogenous inhibitors in normal human brain and Huntington's disease.
    Olsen RW; Van Ness P; Napias C; Bergman M; Tourtellotte WW
    Adv Biochem Psychopharmacol; 1980; 21():451-60. PubMed ID: 6246754
    [No Abstract]   [Full Text] [Related]  

  • 34. Senile plaques in Huntington's disease: a preliminary report.
    Bruyn GW; Roos RA
    Clin Neurol Neurosurg; 1990; 92(4):329-31. PubMed ID: 1963823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study.
    McGeer PL; McGeer EG; Fibiger HC
    Neurology; 1973 Sep; 23(9):912-7. PubMed ID: 4146891
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
    Grafe MR; Forno LS; Eng LF
    J Neuropathol Exp Neurol; 1985 Jan; 44(1):47-59. PubMed ID: 2578185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum.
    Kish SJ; Shannak K; Hornykiewicz O
    Ann Neurol; 1987 Sep; 22(3):386-9. PubMed ID: 2445259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease.
    Kiyama H; Seto-Ohshima A; Emson PC
    Brain Res; 1990 Aug; 525(2):209-14. PubMed ID: 2147568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The EEG in Huntington's chorea: a clinical and neuropathological study.
    Scott DF; Heathfield KW; Toone B; Margerison JH
    J Neurol Neurosurg Psychiatry; 1972 Feb; 35(1):97-102. PubMed ID: 4260288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuropharmacologic approach in Huntington's chorea].
    Agid Y
    Rev Neurol (Paris); 1975 Dec; 131(12):847-65. PubMed ID: 134438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.